Moderate coronary artery calcification means a CT scan has detected a meaningful buildup of calcium deposits in the arteries that supply blood to your heart, with an Agatston score between 100 and 300. This puts you in a middle category: not the earliest stage of calcium buildup, but not yet severe. It signals that atherosclerosis, the gradual narrowing and hardening of arteries, has been developing for years and warrants active management.
What the Agatston Score Means
Coronary artery calcification is measured using a quick, non-invasive CT scan called a coronary calcium scan. The scan exposes you to about 1 to 2 millisieverts of radiation, roughly equivalent to a mammogram, and takes only a few minutes. A computer algorithm then calculates your Agatston score based on how much calcium it detects in your coronary arteries.
The scoring breaks down like this:
- 0: No detectable calcium
- 1 to 99: Mild plaque deposits
- 100 to 300: Moderate plaque deposits
- Over 300: Severe plaque deposits
A moderate score tells you that calcium has been accumulating in your artery walls long enough to form visible deposits. It doesn’t tell you whether those deposits are narrowing the artery enough to restrict blood flow, which would require additional testing. But it does confirm that the disease process is well underway.
How Calcium Builds Up in Your Arteries
Calcium doesn’t just passively settle in your arteries the way mineral scale builds up in a pipe. It’s an active biological process driven by inflammation. When cholesterol accumulates in the inner lining of an artery wall, it triggers an immune response. White blood cells called macrophages flood the area and, over time, many of them die within the growing plaque. As these inflammatory cells die, they release tiny membrane-bound particles that act as seeds for mineral crystals to form.
The crystals start microscopically small, around 5 micrometers across. These microcalcifications can then cluster together into larger punctate deposits, which in turn merge into sheets of calcium within the plaque. The process is fueled by the same risk factors that drive atherosclerosis in general: aging, high cholesterol, diabetes, and chronic inflammation. Smooth muscle cells in the artery wall can even change their behavior and start acting like cartilage-forming cells, actively depositing bone-like material.
One important nuance: tiny, scattered microcalcifications in a plaque’s outer cap can actually increase mechanical stress on the surrounding tissue and make the plaque more vulnerable to rupture. Larger, more stable sheets of calcium, paradoxically, may make a plaque less likely to rupture. This is why the total amount of calcium correlates with overall disease burden and risk, even though the relationship between calcification and any single plaque’s danger is more complex.
What Moderate Calcification Means for Your Risk
A score of 100 or higher carries real clinical weight. In a study following over 7,000 people for about 12 years, those with scores of 100 or above had 4.2 times the risk of a major coronary event compared to those with a score of zero. Their risk of cardiovascular events like heart attack or stroke was 2.3 to 3.4 times higher than people with no detectable calcium.
Even mild calcification (scores of 1 to 99) raised the risk of a major coronary event by about 1.9-fold in the same study. So a moderate score represents a meaningful step up from mild, putting you in a category where most physicians will recommend more aggressive prevention strategies. The presence of any coronary calcium at all is associated with a 2.6- to 4.3-fold increased risk of coronary heart disease compared to a clean scan.
These are population-level statistics, not individual predictions. Your personal risk depends on the full picture: your age, blood pressure, cholesterol levels, family history, whether you smoke, and whether you have diabetes.
How Fast Calcification Progresses
Calcium scores tend to rise over time, but the rate varies enormously depending on your risk factors and whether you’re being treated. Research on progression rates found that people without diabetes who weren’t taking cholesterol-lowering medication saw their calcium volume increase by an average of 17% per year. Those on statin therapy progressed more slowly, at roughly 8% per year.
Diabetes accelerates the process dramatically. People with diabetes who weren’t on statins saw their calcium scores jump by an average of 51% annually. Even with statin treatment, diabetic patients still progressed at about 24% per year. A yearly increase greater than 15% is generally considered true progression rather than measurement variability between scans.
Rapid progression matters because it correlates with worse outcomes. In the same research, people who went on to have heart attacks had been progressing faster: around 21% per year for those without diabetes and 42% per year for those with diabetes. This is one reason some physicians recommend repeat scans every few years for people in the moderate range, to see whether treatment is keeping progression in check.
Treatment and Prevention Strategies
There is no proven way to reverse coronary artery calcification once it’s established. The calcium deposits are essentially permanent. But that’s not the point of treatment. The goal is to stabilize the plaques, slow further buildup, and reduce your overall risk of a heart attack or stroke.
For most people with moderate calcification, cholesterol-lowering medication becomes a strong consideration if it wasn’t already. Current guidelines from the American Heart Association and American College of Cardiology use calcium scores to help guide decisions for people in the “borderline” risk category, where a moderate score can tip the balance toward starting treatment. The data on progression rates supports this: statin therapy roughly cut the annual rate of calcium buildup in half for people without diabetes.
The role of aspirin is less settled. Some research suggests that people with calcium scores of 100 or higher may have a net benefit from low-dose aspirin for primary prevention, but current major guidelines from the AHA and ACC have not yet formally incorporated calcium score-based aspirin recommendations. This is a conversation to have with your physician based on your bleeding risk and overall cardiovascular profile.
Lifestyle changes form the foundation regardless of what medications you take. The interventions with the strongest evidence for cardiovascular protection apply directly here: eating a diet low in saturated fat, exercising regularly, maintaining healthy blood pressure and cholesterol levels, and avoiding tobacco products entirely. None of these will erase existing calcium deposits, but they address the underlying inflammatory process that drives plaque growth and instability.
What a Moderate Score Does Not Tell You
A calcium score measures the total burden of calcified plaque, not the degree of artery narrowing. You can have a moderate score with no significant blockage, or you can have a moderate score with a partially blocked artery. The scan also misses “soft” plaque that hasn’t yet calcified, which can sometimes be more dangerous because it’s more prone to rupture. A calcium score is a risk-stratification tool, not a diagnostic test for blockages.
If you’re having symptoms like chest pain, shortness of breath during exertion, or unusual fatigue, your doctor may recommend additional testing such as a stress test or CT angiography to directly evaluate blood flow and artery narrowing. A moderate calcium score without symptoms typically doesn’t require these additional tests on its own, but it does change how aggressively your risk factors should be managed going forward.